Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBT
2551
Beacon Financial Corp
BBT
$2.66B
| $2.53M | ﹤0.01% |
86,246
+28,999
| +51% | +$883K |
|
|
SYNH
2552
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $2.53M | ﹤0.01% |
47,486
-3,901
| -8% | -$200K |
|
2553
CALL
Aptiv
APTV
$10.3B
| $2.53M | ﹤0.01% |
28,900
+24,300
| +528% | +$2.03M |
|
2554
Empire State Realty Trust
ESRT
$836M
| $2.52M | ﹤0.01% |
176,770
+16,360
| +10% | +$231K |
|
2555
CALL
Martin Marietta Materials
MLM
$33B
| $2.52M | ﹤0.01% |
9,200
+6,500
| +241% | +$1.61M |
|
2556
CALL
Nektar Therapeutics
NKTR
$2.58B
| $2.52M | ﹤0.01% |
9,213
-2,407
| -21% | -$883K |
|
2557
NETSCOUT
NTCT
$2.79B
| $2.52M | ﹤0.01% |
109,105
+13,548
| +14% | +$324K |
|
2558
PUT
Reliance Steel & Aluminium
RS
$21.6B
| $2.51M | ﹤0.01% |
+25,200
| New | +$2.46M |
|
2559
CALL
Boston Scientific
BSX
$71.5B
| $2.51M | ﹤0.01% |
61,600
-65,600
| -52% | -$2.78M |
|
|
BFYT
2560
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $2.5M | ﹤0.01% |
100,395
+92,445
| +1,163% | +$1.94M |
|
|
RDS.A
2561
CALL
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $2.5M | ﹤0.01% |
42,500
-56,700
| -57% | -$3.37M |
|
|
AEL
2562
DELISTED
American Equity Investment Life Holding Company
AEL
| $2.5M | ﹤0.01% |
103,237
-7,516
| -7% | -$182K |
|
2563
CALL
ProShares Ultra QQQ
QLD
$14.1B
| $2.5M | ﹤0.01% |
206,400
+167,200
| +427% | +$2.05M |
|
2564
Hancock Whitney
HWC
$6.24B
| $2.49M | ﹤0.01% |
65,127
-7,595
| -10% | -$289K |
|
2565
Independent Bank
INDB
$3.97B
| $2.49M | ﹤0.01% |
33,390
-25,099
| -43% | -$1.82M |
|
2566
PUT
Analog Devices
ADI
$190B
| $2.49M | ﹤0.01% |
22,300
-21,800
| -49% | -$2.47M |
|
|
NVRO
2567
DELISTED
NEVRO CORP.
NVRO
| $2.49M | ﹤0.01% |
28,953
+9,884
| +52% | +$748K |
|
2568
Frontline
FRO
$8.85B
| $2.49M | ﹤0.01% |
273,208
-314,445
| -54% | -$2.54M |
|
|
2569
CALL
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33B
| $2.49M | ﹤0.01% |
19,500
-519,900
| -96% | -$65.5M |
|
2570
SM Energy
SM
$6.87B
| $2.48M | ﹤0.01% |
256,287
+168,263
| +191% | +$1.72M |
|
|
KW
2571
DELISTED
Kennedy-Wilson Holdings
KW
| $2.48M | ﹤0.01% |
113,238
-9,926
| -8% | -$211K |
|
2572
ICU Medical
ICUI
$4.61B
| $2.48M | ﹤0.01% |
15,528
+9,992
| +180% | +$1.99M |
|
2573
Pricesmart
PSMT
$5.46B
| $2.47M | ﹤0.01% |
34,747
-8,314
| -19% | -$504K |
|
2574
Ericsson
ERIC
$33.3B
| $2.47M | ﹤0.01% |
309,539
+181,966
| +143% | +$1.55M |
|
2575
Spire
SR
$4.85B
| $2.47M | ﹤0.01% |
28,312
-10,689
| -27% | -$901K |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.